VentriPoint Diagnostics (VPT: TSXV) exploded 26.8% Monday to $0.59 per share, pushing member ‘screefer‘ further into the lead of March’s Stock Challenge.
VentriPoint’s stock continues volatility in March
VentriPoint’s stock has been as high as $0.92 per share this month.
Everything started for VentriPoint after the company announced it had received a license from Health Canada for its new VMS-PLUS™ machine and the 4-chamber (4C) heart analysis system. In respect to the news, the company explained,
“This is an expansion of the VMS heart analysis product to include right atrium (RA), left atrium (LA) and left ventricle (LV) chambers of the heart. The VMS was already licensed in Canada for use for the right ventricle (RV).”
Click here to read the entire press release, titled Approval for World’s First Complete Heart Analysis System for 2D Ultrasound Exams Received by Ventripoint.
Despite the epic rally in early March, confidence had faded towards the middle of the month, with its shares dipping below $0.40. In the last week, sentiment has shifted and VentriPoint has been gaining momentum.
VentriPoint – 5 Day Chart
That momentum came to a head today after the company gapped up more than 10 cents to a multi-week high.
On March 15th, Ventripoint Diagnostics announced that it was increasing the maximum gross proceeds of its previously-announced non-brokered private placement from $2,000,000 to $3,200,000 and will now issue up to 10,000,000 units at $0.32 per Unit.
Despite the unit price of this financing, investors chased its shares higher today.
On March 8th, we published an article titled Ventripoint Diagnostics Rebounds after 3 Days of Declines, which highlighted this junior’s epic beginning to the month:
“March 2nd, might be remembered as the best day for any stock on the TSX Venture Exchange in 2017. Ventripoint opened at $0.14, traded to a high of $0.92 before settling at $0.69 per share. The junior biotech stock traded a whopping 44.53 million shares worth nearly $20 million dollars.”
Click here to read the entire article.
screefer’s return tops 250% in March Challenge
Long-time member ‘screefer‘ never looked back after March 2nd; however, his top selection of VentriPoint brought his combined average return to below 150% as recent as last week. With VentriPoint rebounding, screefer could be finishing the month in style and with one of the greatest single month returns in our more than ten-year history.
screefer finished Monday with a 254.53% combined average return thus far in March.
Long-time member, ‘minerjoe‘ is sitting in 2nd place with a rock solid 75.40%. Unless screefer faulters, minerjoe will have to settle with 2nd.
